Live AstraZeneca updates

Live AstraZeneca news coverage of developments with the latest updates. Stay on top of latest AstraZeneca news stories and find out what just happened, what is going on with AstraZeneca. The latest real-time news updates and headlines on AstraZeneca
Private Sector Responds to Trump's Call to Cut Prices
UK Expands Global Talent Visa for Top Researchers
MSK Unveils Gut Healing Molecular Switch Cancer Exploits
Blood Test Foretells Immunotherapy Success in Lung Cancer
Blood Test Predicts Immunotherapy Benefit Early
Datroway EU-Approved for Metastatic TNBC First-Line Use
Sonesitatug Vedotin Boosts Survival in Advanced Gastric Cancer
Ultomiris Phase III Trial Update in Post-Transplant TMA
CHMP Backs Enhertu, Pertuzumab for HER2+ Breast Cancer
CHMP Backs EU Approval of Trixeo for Asthma Maintenance
EU OKs Etcamah Combo for 1st-Line ER+ Breast Cancer
1 in 3 Americans Miss Cholesterol Goals, 75% Untreated
TGA Product Information Safety Updates 20 July
COVID-19 Booster Plans Ensure Long-Lasting Immunity
AstraZeneca Secures Global License for Zegfrovy Drug
Key Benefits of UK-Switzerland FTA
Global Biotech Leaders Converge at UAB's BAC 2026
CARDIO-TTRansform Phase III Trial Update for Wainua
U of T, McMaster Launch Life Sciences Fund with Genesys
AI Tool Enhances Cancer Immunotherapy Response Prediction
Manchester Links Science to Global Pharma Pathways
Lancet: MRNA Vaccines Safe, Effective, Promising
University Alliance Fuels Southern Job, Business Growth
EU Approves Enhertu for HER2+ Metastatic Tumors
Efzimfotase Alfa Boosts Bone Health in Pediatric HPP Trial
EU Recommends Datroway for 1st-Line Breast Cancer Use
Cambridge South Station Opens
KI, Stockholm School Boost Global Health Leaders
Karolinska, SSE Boost Global Health Leaders
ERC Awards KI Researchers for Cancer, Inflammation Cures
Digital Health Tools Transform U.S. Healthcare
9 OMP Customers on 2026 Gartner Top 25 List
TGA Product Information Safety Updates 15 June
Ultomiris Gets US Priority Review for IgA Nephropathy
US OKs Truqap as First PTEN-deficient Prostate Drug
AI Accelerates Molecular Simulations 10,000-Fold
AI Model Boosts Liquid Biopsy Accuracy
Elecoglipron Advances to Phase III in AstraZeneca Trials
GLP-1 Pill Cuts Blood Sugar, Trims Bodyweight
Diabetes Drug Cuts Heart Failure in Genetic Risk Group
Ultomiris Cuts Proteinuria 43% in IgA Nephropathy Trial
Trio of New Ebola Vaccines in Development
Super-fit Show Lower Irregular Heartbeat Risk
Low-Dose Zoladex Unavailable in Australia from Nov
Pain Cant Be Measured by Lie Detector: Heres Why
FORTIFY Launches to Boost EU Health Data Innovation
Research: 1 in 10 High-Risk May Have Hidden Heart Attack
Camizestrant Combo Slows Breast Cancer Progression